
DexCom Prices Upsized $1.1B Notes Offering
DexCom (DXCM) announced today the pricing of its offering of $1.1 billion aggregate principal amount of 0.375% Convertible Senior Notes due 2028 (the “notes”) in a private placement to...
DexCom (DXCM) announced today the pricing of its offering of $1.1 billion aggregate principal amount of 0.375% Convertible Senior Notes due 2028 (the “notes”) in a private placement to...
DexCom , Inc. (Nasdaq: DXCM) (“Dexcom”) announced today that it intends to offer, subject to market conditions and other factors, $1.0 billion aggregate principal amount of Convertible...
A Barclays analyst maintained DexCom (NASDAQ: DXCM) at Equalweight and a price target of $115.00 from a prior price target of %currency%%price%. Prior to this rating, DexCom had 17 buy...
A JPMorgan analyst maintained DexCom (NASDAQ: DXCM) at Overweight and a price target of $150.00 from a prior price target of %currency%%price%. Prior to this rating, DexCom had 17 buy...
A BTIG analyst maintained DexCom (NASDAQ: DXCM) at Buy and a price target of $134.00 from a prior price target of %currency%%price%. Prior to this rating, DexCom had 17 buy ratings, 3 hold...
Investing.com - DexCom (NASDAQ: DXCM) reported first quarter EPS of $0.17, $0.02 better than the analyst estimate of $0.15. Revenue for the quarter came in at $741.5M versus the consensus...
Raymond James analyst Jayson Bedford upgraded DexCom Inc (NASDAQ: DXCM) to Strong Buy from Outperform and increased the price target to $138 from $127. The analyst expects an acceleration...
A Raymond James analyst upgraded DexCom (NASDAQ: DXCM) from Outperform to Strong Buy with a price target of $138.00 from a prior price target of %currency%%price%. Prior to this rating,...
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about...
An UBS analyst initiated new coverage DexCom (NASDAQ: DXCM) Buy rating and a price target of $142.00. Prior to this rating, DexCom had 16 buy ratings, 3 hold ratings, and 1 sell...
DexCom , Inc. (DXCM), today issued the following statement in response to speculation following the developments at Silicon Valley Bank, including a recent CNBC article:“Dexcom does not...
By Sam Boughedda DexCom Inc (NASDAQ:DXCM) shares are down more than 8% Monday afternoon after Abbott Laboratories (NYSE:ABT) announced that the U.S. Food and Drug Administration...
By Sam Boughedda DexCom Inc (NASDAQ:DXCM) shares jumped more than 6% Thursday after it was revealed that Medicare will cover continuous glucose monitors (CGMs) for a wider group of...
By Sam Boughedda Apple (NASDAQ:AAPL) believes it could eventually bring a non-invasive and continuous blood glucose monitoring product to market after hitting major milestones, Bloomberg...
DexCom (DXCM) reported Q4 EPS of $0.34, $0.07 better than the analyst estimate of $0.27. Revenue for the quarter came in at $815.2 million versus the consensus estimate of $809.35...
Investing.com - DexCom (NASDAQ: DXCM) reported fourth quarter EPS of $0.34, $0.07 better than the analyst estimate of $0.27. Revenue for the quarter came in at $815.2M versus the consensus...
By Yasin Ebrahim Investing.com -- The Dow gave up gains to close lower Monday, as falling health care and energy stocks offset tech strength in tech after Treasury yields slipped amid...
After-Hours Stock Movers: Amazon.com (NASDAQ:AMZN) 14% LOWER; {{erl-6435||reported Q3 EPS of $0.28, $0.06 better than the analyst estimate of $0.22. Revenue for the quarter came in at $127.1...
DexCom (DXCM) reported Q3 EPS of $0.28, $0.04 better than the analyst estimate of $0.24. Revenue for the quarter came in at $769.6 million versus the consensus estimate of $751.74...
By Investing.com Staff Shares of DexCom (NASDAQ:DXCM) are 8% higher in early trading Friday after Medicare issued a Local Coverage Decision (LCD) proposal on Thursday for continuous...
By Senad Karaahmetovic Citi analysts made a series of changes in the firm’s coverage of Medical Supplies and Technology ahead of the Q3 earnings season. Overall, they see...
By Sam Boughedda BofA Securities released a research paper to clients Monday outlining the firm's top ten U.S. ideas for the fourth quarter. The list includes nine Buys and one Underperform...
By Yasin Ebrahim Investing.com -- The Dow fell Tuesday, weighed down by rising geopolitical tensions and a slip in Caterpillar on weaker-than-expected revenue. The Dow Jones Industrial...
By Yasin Ebrahim Investing.com -- The S&P 500 swung between gains and losses Tuesday, on rising geopolitical tensions and a surge in U.S. Treasury yields as Federal Reserve members...
By Senad Karaahmetovic Shares of DexCom Inc (NASDAQ:DXCM) plunged more than 12% in premarket Friday following weaker-than-expected Q2 results. {{erl-15951||DexCom reported an adjusted...
Pre-Open Stock Movers: Roku (NASDAQ:ROKU) 26% LOWER; {{erl-1050149||reported Q2 EPS of ($0.82), $0.14 worse than the analyst estimate of ($0.68). Revenue for the quarter came in at $764.4...
By Oliver Gray Investing.com - U.S. stock futures were mostly higher during Thursday’s evening deals following a positive session for major benchmark indices as major technology...
After-Hours Stock Movers: {{erl-1050149||Roku (NASDAQ:ROKU) 25% LOWER; reported Q2 EPS of ($0.82), $0.14 worse than the analyst estimate of ($0.68). Revenue for the quarter came in at $764.4...
DexCom (DXCM) reported Q2 EPS of $0.17, $0.02 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $696.2 million versus the consensus estimate of $700.45...
By Daniel Shvartsman Investing.com - Central Banks and earnings will continue to dominate the week ahead. After the European Central Bank announced an unexpectedly hawkish 50 basis point...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Technology, Basic Materials and Consumer Services sectors propelled shares higher. At the close in NYSE,...
By Sam Boughedda Shares of insulin delivery device maker Insulet (NASDAQ:PODD) have tumbled 12% in early trading Tuesday following a statement from Dexcom (NASDAQ:DXCM) regarding rumors of...
Pre-Open Stock MoversTherapeuticsMD, Inc. (NASDAQ:TXMD) 337% HIGHER; entered into a definitive merger agreement to be acquired by an affiliate of EW Healthcare Partners for $10 per...
Investing.com – U.S. equities were mixed at the close on Tuesday, as gains in the Utilities, Telecoms and Oil & Gas sectors propelled shares higher while losses in the Technology, Consumer...
By Sam Boughedda Investing.com -- Yesterday's rise has been short-lived as U.S. equities slide again Tuesday. Here are your midday movers on May 24th. Snap Inc (NYSE:SNAP) stock has...
Pre-Open Stock Movers:Snap (NYSE:SNAP) 34% LOWER; warns for Q2. The company said since they issued guidance on April 21, 2022, the macroeconomic environment has deteriorated further and...
By Senad Karaahmetovic Dexcom (NASDAQ:DXCM) is in talks to buy out diabetes device maker Insulet Corp (NASDAQ:PODD), according to Bloomberg. The two companies are currently negotiating...
DexCom (DXCM) reported Q1 EPS of $0.32, $0.20 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $628.8 million versus the consensus estimate of $624.47...
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Technology, Telecoms and Consumer Services sectors propelled shares higher. At the close in NYSE, the Dow...
By Sam Boughedda Investing.com — Shares of insulin pump technology firm Insulet Corporation (NASDAQ:PODD) surged more than 15% Friday after it said the U.S. Food and Drug Administration has...
Investing.com – U.S. equities were mixed at the close on Tuesday, as gains in the Utilities, Basic Materials and Consumer Services sectors propelled shares higher while losses in the...
Investing.com – U.S. futures jumped on Wednesday, as midterm elections played out as expected, with Congress split after Democrats won the House of Representatives but Republicans kept...
Investing.com – U.S. equities were mixed at the close on Thursday, as gains in the Technology, Consumer Goods and Consumer Services sectors propelled shares higher while losses in the Basic...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Basic Materials, Utilities and Financials sectors propelled shares higher. At the close in NYSE, the Dow...
* Q2 GDP up 3.1 pct vs. prior est. of 3.0 pct * U.S. jobless claims rise more than expected * Accenture slips after reporting results * Indexes lower: Dow 0.16 pct, S&P 0.10 pct,...
* Q2 GDP up 3.1 pct vs. prior est. of 3.0 pct * U.S. jobless claims rise more than expected * Accenture slips after reporting results * Futures lower: Dow 45 pts, S&P 4.5 pts, Nasdaq...
* Futures lower: Dow 18 pts, S&P 1.5 pts, Nasdaq 6.25 pts By Sruthi Shankar Sept 28 (Reuters) - U.S. stock index futures were little changed on Thursday as investors assessed the new...
Investing.com – U.S. equities were mixed at the close on Friday, as gains in the Industrials, Financials and Technology sectors propelled shares higher while losses in the Oil & Gas, Basic...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.